ArticleScientific reports2025
A Hypergraph powered approach to Phenotype-driven Gene Prioritization and Rare Disease Prediction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Gene Ontology knowledgebase in 2026.Nucleic acids research · 2026Article
- NGS Approaches in Clinical Diagnostics: From Workflow to Disease-Specific Applications.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the time of advancing medical technology, there is a critical issue concerning the misdiagnosis of diseases. The aim of this research is to significantly reduce the occurrence of misdiagnoses in medical practice by leveraging hypergraphs and genomic data to improve diagnostic accuracy. We have designed and implemented a sophisticated computational framework for phenotype-driven disease prediction that leverages hypergraphs and genomic data to enhance the accuracy of disease identification, leading to more precise and timely treatments for patients. The study employed robust ranking algorithms, on a sample of 2130 diseases, 4655 genes and 9541 phenotypes collected from reliable sources of Orphanet and Human Phenotype Ontology (HPO) database to achieve highly favorable outcomes. The proposed method outperforms existing state-of-the-art tools such as Phenomizer and GCN, in terms of both prediction accuracy and processing speed. Notably, it captures 50% of causal genes within the top 10 predictions and 85% within the top 100 predictions and the algorithm maintains a high accuracy rate of 98.09% for the top-ranked gene. In conclusion, our study demonstrated the effectiveness of robust ranking algorithms and hypergraph framework in achieving accurate and reliable results for disease diagnosis. While the study provides valuable insights, it is important to note its limitations, such as the sample size and scope of diseases considered. Future research could explore the integration of additional data sources and refinement of algorithms to further enhance diagnostic capabilities. Overall, this study underscores the potential of algorithmic hypergraph based approaches in advancing medical diagnostics and improving healthcare delivery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.